Avanos Medical issues preliminary Q4/FY2023 results; no figures in filing

AVANOS MEDICAL, INC.

2023-FY EPS reported -$1.32 revenue$673,300,000

Announced selected unaudited preliminary results for Q4 and full year ended Dec 31, 2023.
Press release furnished as Exhibit 99.1 but actual financial data is not included in filing text.
No specific revenue, EPS, or guidance numbers disclosed in this 8-K.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

AVANOS MEDICAL, INC. reported preliminary financial results for the quarter and full-year ended December 31, 2023.

Period: the quarter and full-year ended December 31, 2023
Result: preliminary results

Exact text from the filing

On January 4, 2024, Avanos Medical, Inc. (the “Company”) issued a press release that announced selected, unaudited preliminary financial results for the quarter and full-year ended December 31, 2023.

View on SEC.gov

362 earnings releases filed in the last 30 days. Browse all earnings releases →

AVANOS MEDICAL, INC. filing history →

Source: SEC EDGAR

accession 0001606498-24-000002

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.